Systemic-to-Pulmonary Collateral Flow, as Measured by Cardiac Magnetic Resonance Imaging, Is Associated With Acute Post-Fontan Clinical Outcomes

Background— Systemic-pulmonary collateral (SPC) flow occurs commonly in single ventricle patients after superior cavo-pulmonary connection, with unclear clinical significance. We sought to evaluate the association between SPC flow and acute post-Fontan clinical outcomes using a novel method of quantifying SPC flow by cardiac magnetic resonance (CMR) imaging. Methods and Results— All patients who had SPC flow quantified by CMR imaging before Fontan were retrospectively reviewed to assess for acute clinical outcomes after Fontan completion. Forty-four subjects were included who had Fontan completion between May 2008 and September 2010. SPC flow prior to Fontan measured 1.5±0.9 L/min/m2, accounting for 31±11% of total aortic flow and 44±15% of total pulmonary venous flow. There was a significant linear association between natural log-transformed duration of hospitalization and SPC flow as a proportion of total aortic (rho=0.31, P=0.04) and total pulmonary venous flow (rho=0.29, P=0.05). After adjustment for Fontan type and presence of a fenestration, absolute SPC flow was significantly associated with hospital duration ≥7 days (odds ratio [OR]=9.2, P=0.02) and chest tube duration ≥10 days (OR=22.7, P=0.009). Similar associations exist for SPC flow as a percentage of total aortic (OR=1.09, P=0.048 for hospitalization ≥7 days; OR=1.24, P=0.007 for chest tube duration ≥10 days) and total pulmonary venous flow (OR=1.07, P=0.048 for hospitalization ≥7 days; OR=1.18, P=0.006 for chest tube duration ≥10 days). Conclusions— Increasing SPC flow before Fontan, as measured by CMR imaging, is associated with increased duration of hospitalization and chest tube following Fontan completion.

[1]  M. Fogel,et al.  Pre-Fontan cardiac magnetic resonance predicts post-Fontan length of stay and avoids ionizing radiation. , 2009, The Journal of thoracic and cardiovascular surgery.

[2]  M. Fogel,et al.  Noninvasive Quantification of Systemic-to-Pulmonary Collateral Flow: A Major Source of Inefficiency in Patients With Superior Cavopulmonary Connections , 2009, Circulation. Cardiovascular imaging.

[3]  S. Yoo,et al.  Aortopulmonary Collaterals After Bidirectional Cavopulmonary Connection or Fontan Completion: Quantification With MRI , 2009, Circulation. Cardiovascular imaging.

[4]  F. Pigula,et al.  Factors Associated With Prolonged Recovery After the Fontan Operation , 2008, Circulation.

[5]  H. Yamazawa,et al.  Quantification of collateral aortopulmonary flow in patients subsequent to construction of bidirectional cavopulmonary shunts , 2008, Cardiology in the Young.

[6]  S. Yoo,et al.  Massive systemic-to-pulmonary collateral arteries in the setting of a cavopulmonary shunt and pulmonary venous stenosis , 2007, Cardiology in the Young.

[7]  T. Nakanishi,et al.  Elevated vascular endothelial growth factor levels are associated with aortopulmonary collateral vessels in patients before and after the Fontan procedure. , 2007, American heart journal.

[8]  S. Nicolson,et al.  Outcomes of the Fontan procedure using cardiopulmonary bypass with aortic cross-clamping. , 2006, The Annals of thoracic surgery.

[9]  E. Wu,et al.  Clinical implications of major aortopulmonary collateral arteries in patients with right isomerism. , 2006, The Annals of thoracic surgery.

[10]  A. Rocchini,et al.  Transcatheter occlusion of aortopulmonary shunts during single‐ventricle surgical palliation , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[11]  M. Matsumoto,et al.  Increased vascular endothelial growth factor in patients with cyanotic congenital heart diseases may not be normalized after a Fontan type operation. , 2004, The Annals of thoracic surgery.

[12]  W. Wells,et al.  Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. , 2004, The Journal of thoracic and cardiovascular surgery.

[13]  Masahiro Yoshida,et al.  Vascular endothelial growth factor in children with congenital heart disease. , 2003, The Annals of thoracic surgery.

[14]  J. Furui,et al.  Increased Angiogenic Growth Factor in Cyanotic Congenital Heart Disease , 2003, Pediatric Cardiology.

[15]  S. Nicolson,et al.  Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? , 2002, The Journal of thoracic and cardiovascular surgery.

[16]  K. Kanter,et al.  Management of aortopulmonary collateral arteries in Fontan patients: occlusion improves clinical outcome. , 2002, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[17]  G. Rosenthal,et al.  Angiogenic proteins in the lungs of children after cavopulmonary anastomosis. , 2001, The Journal of thoracic and cardiovascular surgery.

[18]  J. Sistino,et al.  Aortopulmonary collateral flow in the Fontan patient: does it matter? , 2001, The Annals of thoracic surgery.

[19]  D. McElhinney,et al.  Incidence and implications of systemic to pulmonary collaterals after bidirectional cavopulmonary anastomosis. , 2000, The Annals of thoracic surgery.

[20]  G. Rosenthal,et al.  Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. , 2000, The Journal of thoracic and cardiovascular surgery.

[21]  A. Raviele,et al.  Importance of acquired systemic-to-pulmonary collaterals in the Fontan operation. , 1999, The Annals of thoracic surgery.

[22]  R. Spicer,et al.  Aortopulmonary collateral vessels and prolonged pleural effusions after modified Fontan procedures. , 1996, American heart journal.

[23]  R. Spicer,et al.  Factors influencing perioperative morbidity during palliation of the univentricular heart. , 1995, The Annals of thoracic surgery.

[24]  T. Disessa,et al.  Pulmonary/systemic flow ratio in children after cavopulmonary anastomosis. , 1995, Journal of the American College of Cardiology.

[25]  H. Ichikawa,et al.  Extent of aortopulmonary collateral blood flow as a risk factor for Fontan operations. , 1995, The Annals of thoracic surgery.

[26]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[27]  J. Mayer,et al.  Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. , 1993, Journal of the American College of Cardiology.

[28]  P. Heimburg Bronchial Collateral Circulation in Experimental Stenosis of the Pulmonary Artery , 1964, Thorax.